Market Overview

Benzinga's Top Downgrades

Related ATU
UPDATE: Stifel Reiterates On Actuant Corporation As Active Capital Strategy Will Define FY15
Actuant Corporation Q4 Conference Call Highlights
Related XYL
Kelly McAndrew Joins Xylem As Vice President Of Global Public Affairs
Will Xylem (XYL) Miss Earnings Estimates in This Quarter?

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

DateFirmActionFromTo
Sep 2014FBR CapitalDowngradesOutperformMarket Perform
Jun 2014CitigroupMaintainsNeutral
Apr 2014SunTrust Robinson HumphreyUpgradesNeutralBuy

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ATU + ANTH)

Around the Web, We're Loving...

Get Benzinga's Newsletters